Dr. Weyrich's Naturopathic Functional Medicine Notebook is a collection of information on topics of interest
to Dr. Weyrich that may be of interest to the world wide audience.
Due to limitations of time, not all information that Dr. Weyrich knows or would like to further research is
Dr. Weyrich welcomes financial contributions to support specific research topics, as well as copies of
non-free access journal articles for him to review on a topic.
Constructive criticism is also welcome.
Overview of Colitis (Ulcerative Colitis)
Colitis refers to any inflammation of the colon (large intestine).
Complimentary and alternative treatments for ulcerative colitis that are considered below include:
Some practitioners have noted an association with
inflammatory process mediated by homocysteine [Rogers2008, pg 9]. Note that the common
diuretic hydrochlorothiazide (HCTZ) increases homocysteine levels [Westphal2003].
[McCulley2018, pp 28, 35, 62, 89] reports that ulcerative colitis may be a
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of ulcerative colitis
with Immune System Balancing.
Low Dose Naltrexone has been shown to be effective in treating
due to it's immune-modulating effects, with a 67% remission rate [Farmer1985],
Dr. Weyrich suspects that Low Dose Naltrexone may also beneficial in treating other forms of
inflammatory bowel disease, such as ulcerative colitis.
Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of colitis with LDN.
Dysbiotic overgrowth of the gut with Clostridium difficile can give
rise to a potentially fatal inflammation of the colon called pseudomembranous
colitis. This dysbiosis is commonly associated with oral antibiotics,
and is often nosocomial (contracted in a hospital setting).
Since Clostridium difficile is resistant to many common oral
antibiotics, treatment with oral antibiotics tends to kill competing beneficial
bacteria in the gut, allowing the Clostridium difficile to grow